Build, Buy, or Partner: What are the Current Trends for Industry Growth & Organizational Expansion in Clinical Cannabinoid Drug Development
Time: 3:30 pm
day: Day Two
Details:
- What are the pros and cons of the “Build” approach in clinical cannabinoid drug development?
- How does the “Buy” strategy offer speed to market and access to talent?
- What advantages and challenges are associated with forming partnerships in this field?
